About AnGes
About AnGes
Top Message
Values
Mission
Business Area
Business Model
Company Profile
Board of Directors
Locations
History
Alliance Status
Pipeline
Pipeline
Main pipeline products
Product for HGF gene therapy
NF-κB Decoy Oligo DNA
Vaccine
Global Alliance
Global Alliance
EmendoBio, Inc.
MyBiotics Pharma Ltd.
Investor Relations
Investor Relations
IR News
Stock Performance
Financial Reports
Intellectual Property Reports
Other Information Materials
Analyst Report
IR STREET(IR related information)
IR STREET(Email Alerts)
Corporate Brochure
Contact us
COVID-19
Contact us
Site Policy
Privacy Policy
JP
EN
Leading Global in Gene Medicine
About AnGes
TOPIC
Our COVID-19 Related Project
News
All
Development
Product Info
IR
Information
2022.01.19
IR
Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
2021.11.09
IR
AV-001: Government Financial Support for the Development of COVID-19 Therapeutic
2021.11.05
IR
Novel Coronavirus (COVID-19) DNA Vaccine: Results of Phase 1/2 and Phase 2/3 Clinical Trials
2021.11.05
IR
Consolidated Financial Report for the Third Quarter 2021
2021.08.06
IR
Consolidated Financial Report for the Second Quarter 2021
Learn more
Pipeline
Learn more
Global Alliance
Learn more
Contact us
